JP2021514207A5 - - Google Patents
Info
- Publication number
- JP2021514207A5 JP2021514207A5 JP2020566878A JP2020566878A JP2021514207A5 JP 2021514207 A5 JP2021514207 A5 JP 2021514207A5 JP 2020566878 A JP2020566878 A JP 2020566878A JP 2020566878 A JP2020566878 A JP 2020566878A JP 2021514207 A5 JP2021514207 A5 JP 2021514207A5
- Authority
- JP
- Japan
- Prior art keywords
- modified
- viral
- viral vector
- neurons
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024014824A JP2024050766A (ja) | 2018-02-15 | 2024-02-02 | 改変ウイルスカプシド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18156932 | 2018-02-15 | ||
| EP18156932.8 | 2018-02-15 | ||
| PCT/EP2019/053610 WO2019158619A1 (en) | 2018-02-15 | 2019-02-14 | Modified viral capsids |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014824A Division JP2024050766A (ja) | 2018-02-15 | 2024-02-02 | 改変ウイルスカプシド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021514207A JP2021514207A (ja) | 2021-06-10 |
| JP2021514207A5 true JP2021514207A5 (https=) | 2022-02-22 |
Family
ID=61521290
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566878A Pending JP2021514207A (ja) | 2018-02-15 | 2019-02-14 | 改変ウイルスカプシド |
| JP2024014824A Pending JP2024050766A (ja) | 2018-02-15 | 2024-02-02 | 改変ウイルスカプシド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014824A Pending JP2024050766A (ja) | 2018-02-15 | 2024-02-02 | 改変ウイルスカプシド |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20210107947A1 (https=) |
| EP (1) | EP3752521A1 (https=) |
| JP (2) | JP2021514207A (https=) |
| CN (1) | CN112105630A (https=) |
| AU (2) | AU2019220368B2 (https=) |
| BR (1) | BR112020016666A2 (https=) |
| CA (1) | CA3095660A1 (https=) |
| SG (1) | SG11202009854XA (https=) |
| WO (1) | WO2019158619A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023518809A (ja) * | 2020-03-20 | 2023-05-08 | ディグニティー ヘルス | アデノ随伴ウイルスの改変方法及び分離方法 |
| CN116390773A (zh) | 2020-08-06 | 2023-07-04 | 应用医学研究基金会 | 用于通过基因疗法治疗诸如阿尔茨海默病的Tau蛋白病的病毒颗粒 |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| CN115894659B (zh) * | 2022-10-19 | 2023-11-10 | 上海优宁维生物科技股份有限公司 | 微管相关蛋白Tau抗原及其制备方法和应用 |
| WO2024191778A1 (en) | 2023-03-10 | 2024-09-19 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| AU2024332181A1 (en) | 2023-08-31 | 2026-02-12 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2025082618A1 (en) | 2023-10-20 | 2025-04-24 | Fuse Vectors Aps | In vitro parvovirus capsid manufacturing |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6368901A (en) * | 2000-05-31 | 2001-12-11 | Univ Saskatchewan | Modified bovine adenovirus having altered tropism |
| SI1496944T1 (sl) * | 2002-05-01 | 2009-02-28 | Univ Florida | Izboljšani sistemi ekspresije RAAV za genetsko modifikacijo specifičnih kapsidnih proteinov |
| WO2015048534A1 (en) * | 2013-09-26 | 2015-04-02 | University Of Florida Research Foundation, Inc. | Synthetic combinatorial aav capsid library for targeted gene therapy |
| WO2015117010A2 (en) * | 2014-01-31 | 2015-08-06 | Temple University Of The Commonwealth System Of Higher Education | Bag3 as a target for therapy of heart failure |
| EP3200830B1 (en) * | 2014-10-03 | 2020-09-09 | University of Massachusetts | High efficiency library-identified aav vectors |
| AU2016219789B2 (en) * | 2015-02-20 | 2021-03-25 | Fondazione Telethon | Methods and compositions for treating genetic eye diseases |
| US11866462B2 (en) * | 2016-05-04 | 2024-01-09 | Oregon Health & Science University | Recombinant adeno-associated viral vectors |
| AU2017302013B2 (en) * | 2016-07-29 | 2022-05-26 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| AU2017341849B2 (en) * | 2016-10-13 | 2024-03-21 | University Of Massachusetts | AAV capsid designs |
| WO2018119330A2 (en) * | 2016-12-22 | 2018-06-28 | Oregon Health & Science University | Adeno associated viral vectors |
| EP3585883A4 (en) * | 2017-02-21 | 2021-04-14 | University of Florida Research Foundation, Incorporated | MODIFIED AAV CAPSID PROTEINS AND USES THEREOF |
| CA3053154A1 (en) * | 2017-06-30 | 2019-01-03 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsids and methods of use thereof |
-
2019
- 2019-02-14 SG SG11202009854XA patent/SG11202009854XA/en unknown
- 2019-02-14 US US16/970,004 patent/US20210107947A1/en not_active Abandoned
- 2019-02-14 JP JP2020566878A patent/JP2021514207A/ja active Pending
- 2019-02-14 CN CN201980026061.6A patent/CN112105630A/zh active Pending
- 2019-02-14 CA CA3095660A patent/CA3095660A1/en active Pending
- 2019-02-14 EP EP19703748.4A patent/EP3752521A1/en active Pending
- 2019-02-14 AU AU2019220368A patent/AU2019220368B2/en active Active
- 2019-02-14 WO PCT/EP2019/053610 patent/WO2019158619A1/en not_active Ceased
- 2019-02-14 BR BR112020016666-9A patent/BR112020016666A2/pt unknown
-
2024
- 2024-02-02 JP JP2024014824A patent/JP2024050766A/ja active Pending
- 2024-07-01 AU AU2024204557A patent/AU2024204557A1/en active Pending
- 2024-08-13 US US18/802,552 patent/US20250051396A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514207A5 (https=) | ||
| CN115023242B (zh) | 腺相关病毒载体变体 | |
| Löw et al. | Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particles | |
| JP2023525810A5 (https=) | ||
| JP7433360B2 (ja) | Ｐａｈ遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法 | |
| Bowers et al. | Genetic therapy for the nervous system | |
| US11472859B2 (en) | Method and composition for treating neuronal hyper-excitabtiity | |
| CN113121655B (zh) | 眼部和肌肉特异靶向型腺相关病毒载体及其应用 | |
| US9486540B2 (en) | Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders | |
| Li et al. | An overview of the therapeutic strategies for the treatment of spinal muscular atrophy | |
| CN121488045A (zh) | Aav衣壳变体及其用途 | |
| US20200318080A1 (en) | Methods and compositions for treating equine conditions using recombinant self-complementary adeno-associated virus | |
| US20220106613A1 (en) | Neurod1 vector | |
| Meng et al. | Specific gene expression in mouse cortical astrocytes is mediated by a 1740bp-GFAP promoter-driven combined adeno-associated virus2/5/7/8/9 | |
| US20220098254A1 (en) | NEUROD1 and DLX2 VECTOR | |
| US20220098255A1 (en) | Neurod1 combination vector | |
| US20210283222A1 (en) | Methods and compositions for treating canine conditions using recombinant self-complementary adeno-associated virus | |
| Kullmann | Recent progress and challenges in gene therapy for pharmacoresistant focal epilepsy | |
| CN118613590A (zh) | 用于玻璃体内施用的功能性aav衣壳 | |
| CN111093716B (zh) | 用于治疗神经性疼痛的方法和组合物 | |
| Verkuyl et al. | Toward an all-in-one recombinant adeno-associated virus vector for functionally ablating the prion gene using CRISPR-Cas technology | |
| EP4705490A1 (en) | Capsids and methods of targeting nuerons | |
| CN116761812A (zh) | Neurod1和dlx2载体 | |
| WO2025125692A1 (en) | Viral vector for transduction of adipocytes | |
| EP4658800A1 (en) | An aav9 capsid variant for targeted gene transfer |